Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (11728)	1/17/2013 4:38:24 PM
From: SG	2 Recommendations Read Replies (2) \| Respond to of 13111

I'm finally out of here, taking my 85% loss in non-deductible IRA stock. The falling stock price, somewhat ludicrous Phase I study of the bystander effect this late, and the class action lawsuit just tell me that there's more chance of an asteroid hitting us than something being brought to the market from this company. Shareholders have been screwed with falling stock prices while management awards itself salaries and options that are way beyond what a company in this position should have paid. Hilariously, shareholder money, no doubt, will now also be spent on legal fees fighting the class action lawsuit. If these meds work it's a shame that despite innumerable patents and applications, there are no products that have been approved. The starry-eyed longs, if they actually owned the vast shares as claimed, left this board long ago. I bought it to further my retirement and it has done the opposite. Certainly, I was not forced to buy the stock but I have been greatly annoyed and disappointed at the lack of ability of management to bring a product to market. I have retained a paltry 1000 shares as lottery tickets in the grossly uncertain event that our blockbuster cure makes it to market. At least I won't be inclined to follow my shares anymore, with constant aggravation.